910 results
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022
CHMP, Last updated: 25/02/2022 -
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market (updated)
CMDh, Last updated: 26/07/2022 -
List item
News: EMA recommends authorisation of booster doses of Comirnaty from 12 years of age
CHMP, Last updated: 24/02/2022 -
List item
News: EMA recommends approval of Spikevax for children aged 6 to 11
CHMP, PDCO, Last updated: 24/02/2022 -
List item
News: EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty in adolescents
CHMP, Last updated: 08/02/2022 -
List item
News: New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma
CHMP, Last updated: 28/01/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
News: Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
CHMP, Last updated: 24/01/2022 -
List item
News: COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
CHMP, PRAC, Last updated: 18/01/2022 -
List item
News: EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19
CHMP, PRAC, Last updated: 10/01/2022 -
List item
News: EMA recommends Nuvaxovid for authorisation in the EU
CHMP, Last updated: 20/12/2021 -
List item
News: New treatment for sickle cell disease
CHMP, Last updated: 17/12/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2021
CHMP, Last updated: 17/12/2021 -
List item
News: EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19: rolling review starts in parallel
CHMP, Last updated: 16/12/2021 -
List item
News: Increase in manufacturing capacity for COVID-19 vaccines from Janssen, Moderna and BioNTech/Pfizer
CHMP, Last updated: 16/12/2021 -
List item
News: COVID-19: EMA recommends authorisation of antibody medicine Xevudy
CHMP, Last updated: 16/12/2021 -
List item
News: EMA recommends approval for use of Kineret in adults with COVID-19
CHMP, Last updated: 16/12/2021 -
List item
News: COVID-19 Vaccine Janssen: EMA recommendation on booster dose
CHMP, Last updated: 15/12/2021 -
List item
News: EMA recommends approval for use of RoActemra in adults with severe COVID-19
CHMP, Last updated: 06/12/2021 -
List item
News: EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001)
CHMP, Last updated: 02/12/2021 -
List item
News: Increase in manufacturing capacity for COVID-19 vaccine from AstraZeneca
CHMP, Last updated: 01/12/2021 -
List item
News: Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11
CHMP, Last updated: 25/11/2021 -
List item
News: EMA receives application for marketing authorisation for Lagevrio (molnupiravir) for treating patients with COVID 19
CHMP, Last updated: 23/11/2021 -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 November 2021
Online, 25/11/2021, Last updated: 23/11/2021